314 filings
Page 4 of 16
SC 13D/A
h3o1aqmgddsrjyg
19 Apr 23
Checkpoint Therapeutics / Fortress Biotech ownership change
4:24pm
D
2fsz3n911rir6m6b
14 Apr 23
Indefinite amount in options / securities to be acquired, 9 investors
5:00pm
UPLOAD
we4d ockry334the
14 Apr 23
Letter from SEC
12:00am
4
yxvltkm5cpd2tx0o8m
4 Apr 23
Checkpoint Therapeutics / James F Oliviero III ownership change
8:30pm
4
fvkgkx
4 Apr 23
Checkpoint Therapeutics / WILLIAM GARRETT GRAY ownership change
8:30pm
4
zf9f4hme
4 Apr 23
Change in insider ownership
4:06pm
8-K
cpizsuu119m1sxd
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
424B5
jo1wwk
4 Apr 23
Prospectus supplement for primary offering
6:03am
8-K
s3e hcwons9ip
31 Mar 23
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
6:00am
8-K
idf5z4bbg ybjfp3b
10 Mar 23
Regulation FD Disclosure
5:07pm
4
fudo6 v9gq410r
3 Mar 23
Checkpoint Therapeutics / James F Oliviero III ownership change
8:00pm
4
8h1y98 m1r9faoqauf
3 Mar 23
Checkpoint Therapeutics / WILLIAM GARRETT GRAY ownership change
8:00pm
D
mpokrv 6uv
3 Mar 23
Indefinite amount in options / securities to be acquired, 1 investor
5:15pm
8-K
5galj6q
2 Mar 23
FDA indicates that it does not currently plan to hold an advisory committee meeting
7:30am
8-K
lzpuhrwlwp j89ijagj
22 Feb 23
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:00pm
424B5
ft38gx7y0orzk7vtoaf2
22 Feb 23
Prospectus supplement for primary offering
4:56pm